Back
PDS Biotechnology Vs. Cellectar Biosciences Industry Stock Comparison
Sell
44
PDSB
PDS Biotechnology
Last Price:
3.24
Seasonality Move:
3.52%
Sell
40
CLRB
Cellectar Biosciences
Last Price:
2.04
Seasonality Move:
-1.23%
Sell
44
PDS Biotechnology (PDSB)
is a Sell
Is PDS Biotechnology a Buy, Sell or Hold?
- The current PDS Biotechnology [PDSB] share price is $3.20. The Score for PDSB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- PDSB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $2.03. The Score for CLRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PDSB Stock Price Chart
What is PDS Biotechnology's stock price today?
-
The PDS Biotechnology share price today is $3.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDSB is experiencing slight selling pressure.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $2.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight buying pressure.
PDSB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.46 | Sell |
| Chaikin Money Flow: | -125040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.11 - 3.67) | Sell |
| Bollinger Bands (100): | (2.91 - 3.65) | Sell |
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 44.93 | Sell |
| Chaikin Money Flow: | 15400 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.04 - 2.14) | Sell |
| Bollinger Bands (100): | (1.93 - 2.59) | Sell |
PDSB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.18 | Buy |
| 20-day SMA: | 3.3 | Sell |
| 50-day SMA: | 3.25 | Sell |
| 200-day SMA: | 3.77 | Sell |
| 8-day EMA: | 3.21 | Sell |
| 20-day EMA: | 3.26 | Sell |
| 50-day EMA: | 3.29 | Sell |
| 200-day EMA: | 3.76 | Sell |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.05 | Sell |
| 20-day SMA: | 2.08 | Sell |
| 50-day SMA: | 2.09 | Sell |
| 200-day SMA: | 2.87 | Sell |
| 8-day EMA: | 2.05 | Sell |
| 20-day EMA: | 2.07 | Sell |
| 50-day EMA: | 2.12 | Sell |
| 200-day EMA: | 2.51 | Sell |
PDS Biotechnology Earnings Growth & PDSB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.24 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
PDS Biotechnology Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cellectar Biosciences Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||